Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events groundbreaking method dealing missing patient reported outcome pro data oncology
… PRO Analysis Portfolio Across Multiple Cancers OPPORTUNITY … partner to plan, analyze, and create reports for the patient-reported health-related quality-of-life (HRQOL) data …
… and evaluated the psychometric properties of hundreds of PRO instruments and other types of COAs to assess health … health-related quality of life, functional status, and patient satisfaction for use in clinical trials involving … developing COAs for use in routine clinical care, such as patient screeners and disease management tools. Our …
… to get what is important to them? For example, if your patient has to choose between a highly effective drug with a … have learned is that traditional health economics , patient-reported outcomes (PROs) and the patient’s point-of-view are …
… It is important that the best use of the available data in a network is achieved. This means that a number of … are able to fit MTCs to wide variety of different types of data including: Binomial responses including adjustment for … responses including a mixture of binomial and ordinal data Survival outcomes Poisson outcomes including …
… and Projected Value Assessments: Clinical, economic, PRO /QoL value A Roadmap: Tactical project and study …
… Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide variety of … acceptable to the FDA following the release of the FDA’s PRO Guidance. To support these efforts, we have developed … as well as guiding industry clients through the EMA’s PRO Scientific Advice and Biomarker qualification processes. …
… and Insights From ASCO 2024: A Glimpse Into the Future of Oncology Share on: June 12, 2024 The ASCO 2024 conference … insights that emerged from the event: Genomic/Biomarker Data: Revolutionizing Cancer Treatment There is a push to … diagnosis and regular monitoring, all of which can improve patient outcomes. Biopharma can use these data for research …
… the product's safety and/or effectiveness using real-world data (RWD). This most often involves causal inference … diverse backgrounds such as clinicians, trialists, and data holders. Once the target trial has been specified, we … target trial framework using diverse types of real-world data. See examples of studies we have conducted using various …
… matter most to your patients? As a stated-preference method, discrete-choice experiments (DCE)/conjoint analysis … with different sets of benefits and potential adverse events. Treatment attributes are relative based on a person’s … for each study that are representative of the target patient population(s). Our experience includes numerous …
… 2022 International Thoracic Surgical Oncology Summit Share on: Friday, September 30 - Saturday, … be presented at the 2022 International Thoracic Surgical Oncology Summit. Veluswamy R, Ahn MJ, Nagar S, Affi R, …